With the focus on improving patient experience and reducing burden on sites PHILADELPHIA , June 27, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, announced the early adopter launch of its ePatient product. This innovative solution is designed to address the complexities, inefficiencies, and frustrations patients encounter with stipend and reimbursement payments, as well as appointment management , throughout their clinical trial journey. ePatient is set to transform the patient experience by unifying payments, appointments, reminders, and eCOA questionnaires into a single user-friendly mobile interface with the simple, intuitive design Suvoda is known for.
The application's seamless integration with Suvoda's IRT and eConsent ensures a cohesive user experience, enabling site users and patients to move effortlessly between all Suvoda products with a single sign-on. "By listening to the needs of our customers and leveraging our expertise in clinical trial technology, we have created a solution that not only improves the patient experience but also enhances operational efficiency for all stakeholders involved," said Elizabeth Morris , Senior Product Manager at Suvoda. Suvoda ePatient is expected to deliver four key benefits.
Faster Patient Payments: Streamlined patient stipend and reimbursement payments with automated triggers, red.
